Clearance Summary
SELISA ANTI-N DNA ANTIBODIES received FDA 510(k) clearance under submission number K940585, sponsored by Cambridge Life Sciences Plc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Immunology review panel. The statutory decision date of record is 1994-06-10.
- Submission: K940585
- Applicant / Sponsor: Cambridge Life Sciences Plc.
- Clearance pathway: Traditional
- Review panel: Immunology
- Device class: Class II
- Regulation citation: 21 CFR 866.5100
- Decision date: 1994-06-10
Classification & Regulation
This clearance is catalogued under FDA product code LRM and 21 CFR 866.5100, within the Immunology review panel as a Class II device.